These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35980554)

  • 1. Tumor Growth Rate as a Predictive Marker for Recurrence and Survival After Liver Resection in Patients with Liver Metastases of Uveal Melanoma.
    Ramtohul T; Abdul-Baki M; Rodrigues M; Cassoux N; Gardrat S; Ait Rais K; Pierron G; Bouhadiba T; Servois V; Mariani P
    Ann Surg Oncol; 2022 Dec; 29(13):8480-8491. PubMed ID: 35980554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour growth rate improves tumour assessment and first-line systemic treatment decision-making for immunotherapy in patients with liver metastatic uveal melanoma.
    Ramtohul T; Cohen A; Rodrigues M; Piperno-Neumann S; Cabel L; Cassoux N; Lumbroso-Le Rouic L; Malaise D; Gardrat S; Pierron G; Mariani P; Servois V
    Br J Cancer; 2022 Jul; 127(2):258-267. PubMed ID: 35347325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Clinico-Genetic Score Incorporating Disease-Free Intervals and Chromosome 8q Copy Numbers: A Novel Prognostic Marker for Recurrence and Survival Following Liver Resection in Patients with Liver Metastases of Uveal Melanoma.
    Mariani P; Pierron G; Ait Rais K; Bouhadiba T; Rodrigues M; Malaise D; Lumbroso-Le Rouic L; Barnhill R; Stern MH; Servois V; Ramtohul T
    Cancers (Basel); 2024 Oct; 16(19):. PubMed ID: 39410027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection for metastatic uveal melanoma: experience from a supra-regional centre and review of literature.
    Trivedi DB; Aldulaimi N; Karydis I; Wheater M; Modi S; Stedman B; Karavias D; Primrose J; Pearce N; Takhar AS
    Melanoma Res; 2023 Feb; 33(1):71-79. PubMed ID: 36409208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Disease-Free Interval Between Resection of Primary Colorectal Malignancy and the Detection of Hepatic Metastases Predicts Disease Recurrence But Not Overall Survival.
    Höppener DJ; Nierop PMH; van Amerongen MJ; Olthof PB; Galjart B; van Gulik TM; de Wilt JHW; Grünhagen DJ; Rahbari NN; Verhoef C
    Ann Surg Oncol; 2019 Sep; 26(9):2812-2820. PubMed ID: 31147988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Tumor Growth Rate and Radiological Response as Predictive Markers of Pathological Response and Survival in Patients with Resectable Lung Cancer Treated by Neoadjuvant Treatment.
    Ramtohul T; Challier L; Servois V; Girard N
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma.
    Mariani P; Almubarak MM; Kollen M; Wagner M; Plancher C; Audollent R; Piperno-Neumann S; Cassoux N; Servois V
    Eur J Surg Oncol; 2016 May; 42(5):706-12. PubMed ID: 26968227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.
    Eldredge-Hindy H; Ohri N; Anne PR; Eschelman D; Gonsalves C; Intenzo C; Bar-Ad V; Dicker A; Doyle L; Li J; Sato T
    Am J Clin Oncol; 2016 Apr; 39(2):189-95. PubMed ID: 24441583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience.
    Rose DM; Essner R; Hughes TM; Tang PC; Bilchik A; Wanek LA; Thompson JF; Morton DL
    Arch Surg; 2001 Aug; 136(8):950-5. PubMed ID: 11485537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of liver metastases from uveal melanoma.
    Kodjikian L; Grange JD; Baldo S; Baillif S; Garweg JG; Rivoire M
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):985-93. PubMed ID: 15891893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic analysis of colorectal liver metastases treated by surgery combined with intraoperative radiofrequency ablation].
    Mao R; Zhao JJ; Bi XY; Zhao H; Li ZY; Huang Z; Zhang YF; Chen X; Hu HJ; Wu XL; Hu XH; Cai JQ
    Zhonghua Wai Ke Za Zhi; 2017 Jul; 55(7):521-527. PubMed ID: 28655081
    [No Abstract]   [Full Text] [Related]  

  • 12. Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy.
    He LN; Zhang X; Li H; Chen T; Chen C; Zhou Y; Lin Z; Du W; Fang W; Yang Y; Huang Y; Zhao H; Hong S; Zhang L
    Front Oncol; 2020; 10():621329. PubMed ID: 33552993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Implications of MRI Melanin Quantification and Cytogenetic Abnormalities in Liver Metastases of Uveal Melanoma.
    Ramtohul T; Ait Rais K; Gardrat S; Barnhill R; Román-Román S; Cassoux N; Rodrigues M; Mariani P; De Koning L; Pierron G; Servois V
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases.
    Ludwig J; Haubold J; Heusner TA; Bauer S; Siveke JT; Richly H; Wetter A; Umutlu L; Theysohn JM
    Rofo; 2021 Jun; 193(6):683-691. PubMed ID: 33348383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protracted survival after resection of metastatic uveal melanoma.
    Aoyama T; Mastrangelo MJ; Berd D; Nathan FE; Shields CL; Shields JA; Rosato EL; Rosato FE; Sato T
    Cancer; 2000 Oct; 89(7):1561-8. PubMed ID: 11013372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
    Dromain C; Pavel ME; Ruszniewski P; Langley A; Massien C; Baudin E; Caplin ME;
    BMC Cancer; 2019 Jan; 19(1):66. PubMed ID: 30642293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive recurrences determine oncologic outcomes after resection of liver metastases from primary right colon cancer: Results of a case-control study.
    Zimmitti G; Panettieri E; Ardito F; Mele C; Maria V; Rosso E; Nuzzo G; Giuliante F
    Eur J Surg Oncol; 2021 Apr; 47(4):834-841. PubMed ID: 33032866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iterative treatment with surgery and radiofrequency ablation of uveal melanoma liver metastasis: Retrospective analysis of a series of very long-term survivors.
    Servois V; Bouhadiba T; Dureau S; Da Costa C; Almubarak MM; Foucher R; Savignoni A; Cassoux N; Pierron G; Mariani P
    Eur J Surg Oncol; 2019 Sep; 45(9):1717-1722. PubMed ID: 31266665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Prognostic Nomogram for Liver Metastasis of Uveal Melanoma Patients Selected by Liver MRI.
    Mariani P; Dureau S; Savignoni A; Rouic LL; Levy-Gabriel C; Piperno-Neumann S; Rodrigues MJ; Desjardins L; Cassoux N; Servois V
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.